Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Permethrin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    13 result(s) found for: Permethrin. Displaying page 1 of 1.
    EudraCT Number: 2022-000660-22 Sponsor Protocol Number: Benzylbenzoat-Permethrin-5020 Start Date*: 2022-06-14
    Sponsor Name:Landeskrankenhaus Salzburg
    Full Title: Investigation to assess the efficacy of topical benzyl benzoate 10/25% emulsion versus permethrin 5% creme for scabies treatment
    Medical condition: Scabies
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006776-11 Sponsor Protocol Number: 07ct/am06perm Start Date*: 2008-02-20
    Sponsor Name:gepepharm GmbH
    Full Title: Investigation of the local tolerability of pedimitex Lösung 0.5% - a permethrin containing solution - in 100 patients with head lice infection of both gender
    Medical condition: The product is intended to be used by patients suffering from head lice infestation.
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-006190-87 Sponsor Protocol Number: CTOM01 Start Date*: 2008-03-04
    Sponsor Name:Omega Pharma N.V.
    Full Title: A randomised, controlled, assessor-blind, clinical trial to investigate superiority of Lyclear spray away (ParaNix spray) compared with Infectopedicul permethrin 0.5% lotion in the treatment of hea...
    Medical condition: Infestation by head lice (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019199 Head pediculosis LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004494-27 Sponsor Protocol Number: 5020DERM-2018 Start Date*: Information not available in EudraCT
    Sponsor Name:Landeskrankenhaus Salzburg
    Full Title: pilotstudy- efficacy of infectoscab 5% creme in patients with scabies
    Medical condition: Scabies
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10039511 Scabies LLT
    20.0 10021881 - Infections and infestations 10063409 Acarodermatitis PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-003234-16 Sponsor Protocol Number: ETSKABI Start Date*: 2021-01-26
    Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH
    Full Title: Prospektive, offene, multizentrische, initial 1-armige und bei Therapieversagen 3-armig randomisierte klinische Prüfung der Phase III/IV zur eskalierenden Therapie der Skabies mit INFECTOSCAB 5% (P...
    Medical condition: Scabies
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006778-26 Sponsor Protocol Number: 07ct/am04perm Start Date*: 2008-07-17
    Sponsor Name:gepepharm GmbH
    Full Title: Investigation of the local tolerability of pedimitex creme 5% - a permethrine containing creme - in 100 patients with scabies infection of both gender
    Medical condition: The product is intended to be used by patients suffering from scabies infestation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039512 Scabies infestation LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-019804-21 Sponsor Protocol Number: CTWE01 Start Date*: 2010-05-18
    Sponsor Name:Wepa Apothekenbedarf GmbH & Co KG
    Full Title: A randomised, controlled, assessor-blind, clinical investigation of the activity of mosquito® LäuseShampoo compared with Infectopedicul® permethrin 0.5% lotion in the treatment of head lice
    Medical condition: Infestation by head lice (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019199 Head pediculosis LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-023566-43 Sponsor Protocol Number: PAROP Start Date*: 2012-02-23
    Sponsor Name:INFECTOPHARM Arzneimittel GmbH
    Full Title: Multizentrische, randomisierte, doppelblinde, kontrollierte Phase III-Studie zur Behandlung der papulopustulären Rosazea mit Permethrin Creme 5 % (InfectoScab®) versus Permethrin Creme 2,5 % versus...
    Medical condition: Rosacea
    Disease: Version SOC Term Classification Code Term Level
    14.1 10040785 - Skin and subcutaneous tissue disorders 10039218 Rosacea PT
    14.1 10040785 - Skin and subcutaneous tissue disorders 10000514 Acne rosacea LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-001892-38 Sponsor Protocol Number: CTPN01 Start Date*: 2011-07-22
    Sponsor Name:Panin S.r.l.
    Full Title: A randomised, controlled, assessor-blind, clinical trial to compare Liceko ® with NIX/Lyclear 1% permethrin crème rinse in the treatment of head lice.
    Medical condition: Head louse infestation (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    13.1 10021881 - Infections and infestations 10034214 Pediculus capitis (head louse) LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-000257-23 Sponsor Protocol Number: CTMK13 Start Date*: 2011-06-14
    Sponsor Name:Thornton & Ross Ltd
    Full Title: A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice
    Medical condition: Head louse infestation (pediculosis capitis)
    Disease: Version SOC Term Classification Code Term Level
    13.1 10021881 - Infections and infestations 10034214 Pediculus capitis (head louse) LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002022-22 Sponsor Protocol Number: CT 205 Start Date*: 2004-12-01
    Sponsor Name:SSL International plc
    Full Title: A phase II randomised, controlled, assessor-blind, parallel group clinical trial to demonstrate the proof of concept of an experimental pediculicide rinse and Lyclear Creme Rinse in the treatment o...
    Medical condition: Head lice infestation
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004084-37 Sponsor Protocol Number: CT214 Start Date*: 2005-11-11
    Sponsor Name:SSL International plc
    Full Title: A phase III, randomised, controlled, assessor-blind, parallel group clinical trial to confirm the safety and efficacy of an experimental pediculicide rinse and Lyclear Creme Rinse in the treatment ...
    Medical condition: Head lice infestation
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-004635-20 Sponsor Protocol Number: P1605NY Start Date*: 2017-03-24
    Sponsor Name:G. Pohl-Boskamp GmbH & Co. KG
    Full Title: A monocentric, randomized, controlled, investigator-blind trial to evaluate the efficacy and safety of an investigational medical device (PB790) in subjects with head lice.
    Medical condition: Headlice infestation
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10019197 Head lice LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 04:33:08 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA